TY - JOUR
T1 - Genetic associations with lipoprotein subfractions provide information on their biological nature
AU - Petersen, Ann Kristin
AU - Stark, Klaus
AU - Musameh, Muntaser D.
AU - Nelson, Christopher P.
AU - Römisch-Margl, Werner
AU - Kremer, Werner
AU - Raffler, Johannes
AU - Krug, Susanne
AU - Skurk, Thomas
AU - Rist, Manuela J.
AU - Daniel, Hannelore
AU - Hauner, Hans
AU - Adamski, Jerzy
AU - Tomaszewski, Maciej
AU - Döring, Angela
AU - Peters, Annette
AU - Wichmann, H. Erich
AU - Kaess, Bernhard M.
AU - Kalbitzer, Hans Robert
AU - Huber, Fritz
AU - Pfahlert, Volker
AU - Samani, Nilesh J.
AU - Kronenberg, Florian
AU - Dieplinger, Hans
AU - Illig, Thomas
AU - Hengstenberg, Christian
AU - Suhre, Karsten
AU - Gieger, Christian
AU - Kastenmüller, Gabi
N1 - Funding Information:
The KORA research platform was initiated and financed by the Helmholtz Center Munich, German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Part of this work was financed by the German National Genome Research Network (NGFN-2, NGFNPlus 01GS0823, NGFNPlus 01GS0832 and NGFNPlus 01GS0834) and through additional funds from the University of Ulm and the University Hospital Regensburg. Our research was supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ and by a grant from the BMBF to the German Center for Diabetes Research (DZD e.V.), as well as from the BMBF-funded German Network for Mitochondrial Disorders (mitoNET 01GM0862). Furthermore, the study received funding from the European Community’s Seventh Framework Program (FP7/2007 – 2013), ENGAGE project, grant agreement HEALTH-F4-2007-201413. In addition, the KORA study as well as the trial of the lipid-tolerance test were funded by the BMBF project Systems Biology of Metabotypes (SysMB0 0315494A and 0315494D). A.-K.P is supported by the ENGAGE Exchange and Mobility Program (HEALTH-F4-2007-201413). J.R. is supported by DFG Gra-duiertenkolleg ‘GRK 1563, Regulation and Evolution of Cellular Systems’ (RECESS) and W.R.-M. by BMBF grant 03IS2061B (project Gani_Med). Recruitment and genotyping of the Genetic Regulation of Arterial Pressure of Humans in the Community cohort was funded by the British Heart Foundation. N.J.S. holds a British Heart Foundation Chair of Cardiology. This study is part of the research portfolio supported by the Leicester National Institute for Health Research Biomedical Research Unit in Cardiovascular Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We express our appreciation to all study participants.
PY - 2012/3
Y1 - 2012/3
N2 - Adverse levels of lipoproteins are highly heritable and constitute risk factors for cardiovascular outcomes. Hitherto, genome-wide association studies revealed 95 lipid-associated loci. However, due to the small effect sizes of these associations large sample numbers (>100 000 samples) were needed. Here we show that analyzing more refined lipid phenotypes, namely lipoprotein subfractions, can increase the number of significantly associated loci compared with bulk high-density lipoprotein and low-density lipoprotein analysis in a study with identical sample numbers. Moreover, lipoprotein subfractions provide novel insight into the human lipid metabolism. We measured 15 lipoprotein subfractions (L1-L15) in 1791 samples using 1H-NMR (nuclear magnetic resonance) spectroscopy. Using cluster analyses, we quantified inter-relationships among lipoprotein subfractions. Additionally, we analyzed associations with subfractions at known lipid loci. We identified five distinct groups of subfractions: one (L1) was only marginally captured by serum lipids and therefore extends our knowledge of lipoprotein biochemistry. During a lipid-tolerance test, L1 lost its special position. In the association analysis, we found that eight loci (LIPC, CETP, PLTP, FADS1-2-3, SORT1, GCKR, APOB, APOA1) were associated with the subfractions, whereas only four loci (CETP, SORT1, GCKR, APOA1) were associated with serum lipids. For LIPC, we observed a 10-fold increase in the variance explained by our regression models. In conclusion, NMR-based fine mapping of lipoprotein subfractions provides novel information on their biological nature and strengthens the associations with genetic loci. Future clinical studies are now needed to investigate their biomedical relevance.
AB - Adverse levels of lipoproteins are highly heritable and constitute risk factors for cardiovascular outcomes. Hitherto, genome-wide association studies revealed 95 lipid-associated loci. However, due to the small effect sizes of these associations large sample numbers (>100 000 samples) were needed. Here we show that analyzing more refined lipid phenotypes, namely lipoprotein subfractions, can increase the number of significantly associated loci compared with bulk high-density lipoprotein and low-density lipoprotein analysis in a study with identical sample numbers. Moreover, lipoprotein subfractions provide novel insight into the human lipid metabolism. We measured 15 lipoprotein subfractions (L1-L15) in 1791 samples using 1H-NMR (nuclear magnetic resonance) spectroscopy. Using cluster analyses, we quantified inter-relationships among lipoprotein subfractions. Additionally, we analyzed associations with subfractions at known lipid loci. We identified five distinct groups of subfractions: one (L1) was only marginally captured by serum lipids and therefore extends our knowledge of lipoprotein biochemistry. During a lipid-tolerance test, L1 lost its special position. In the association analysis, we found that eight loci (LIPC, CETP, PLTP, FADS1-2-3, SORT1, GCKR, APOB, APOA1) were associated with the subfractions, whereas only four loci (CETP, SORT1, GCKR, APOA1) were associated with serum lipids. For LIPC, we observed a 10-fold increase in the variance explained by our regression models. In conclusion, NMR-based fine mapping of lipoprotein subfractions provides novel information on their biological nature and strengthens the associations with genetic loci. Future clinical studies are now needed to investigate their biomedical relevance.
UR - http://www.scopus.com/inward/record.url?scp=84857680629&partnerID=8YFLogxK
U2 - 10.1093/hmg/ddr580
DO - 10.1093/hmg/ddr580
M3 - Article
C2 - 22156577
AN - SCOPUS:84857680629
SN - 0964-6906
VL - 21
SP - 1433
EP - 1443
JO - Human Molecular Genetics
JF - Human Molecular Genetics
IS - 6
M1 - ddr580
ER -